Health
Recurring glioblastomas with very few mutations are far more vulnerable to immunotherapies – News-Medical.Net
Glioblastoma brain tumors are especially perplexing. Inevitably lethal, the tumors occasionally respond to new immunotherapies after they’ve grown back, enabling…
Glioblastoma brain tumors are especially perplexing. Inevitably lethal, the tumors occasionally respond to new immunotherapies after they’ve grown back, enabling up to 20% of patients to live well beyond predicted survival times.
What causes this effect has long been the pursuit of researchers hoping to harness immunotherapies to extend more lives.
New insights from a team led by Duke’s Preston Robert Tisch Brain Tumor Center provide potential answers. The team found that recurring glioblastoma…
-
General24 hours agoNetanyahu denounces report IDF soldiers had orders to shoot Gaza aid-seekers
-
General20 hours agoAustralian racing driver James Wharton takes maiden Formula 3 race win
-
Business14 hours agoBuy and hold NDQ and these ASX ETFs for 10 years
-
General16 hours ago“Accumulation of defects”. A-G report scathing on Navy shipbuilding